319 News & Informationen zur Abbvie Aktie

  • Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in...
    asiaone.com

    Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Ce

    Junshi and Coherus Biosciences Announce Positive Interim Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

    GlobeNewswire

    August 19, 2021

    – Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone – SHANGHAI, China,…

  • New England Journal of Medicine Publishes 12-Week Results from Study Evaluating Atogepant for the Preventive Treatment of Migraine
    markets.businessinsider.com

    New England Journal of Medicine Publishes 12-Week Results from Study Evaluating Atogepant for the Preventive Treatment of Migraine

    NORTH CHICAGO, Ill., Aug. 18, 2021 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the New England Journal of Medicine (NEJM) has publish…

  • New Software Functionality from Unisy
    scoop.co.nz

    New Software Functionality from Unisy

    Technology available to airlines, narrows the gap on the industry challenge of supply chain visibility   Unisys Corporation (NYSE: UIS) today announced the availability of software functionality that for the first time enables airlines to track the status …

  • Global Regenerative Medicine Markets, 2021-2029: Focus On Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics
    thestreet.com

    Global Regenerative Medicine Markets, 2021-2029: Focus On Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics

    DUBLIN, Aug. 18, 2021 /PRNewswire/ — The

  • Global Regenerative Medicine Markets, 2021-2029: Focus on Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics
    prnewswire.com

    Global Regenerative Medicine Markets, 2021-2029: Focus on Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule & Biologics

    /PRNewswire/ — The

  • Stocks That Hit 52-Week Highs On Wednesday
    benzinga.com

    Stocks That Hit 52-Week Highs On Wednesday

    Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
    Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market …

  • 10 Best Healthcare Dividend Stocks to Buy Now
    insidermonkey.com

    10 Best Healthcare Dividend Stocks to Buy Now

    In this article, we will be looking at the 10 best healthcare dividend stocks to buy now.

  • Current Warren Buffett Portfolio 2021: Q2 Update
    newtraderu.com

  • Warren Buffett cuts stakes in pharma stocks, exits Biogen; Nifty Pharma tanks 4% in 1 month
    financialexpress.com

    Warren Buffett cuts stakes in pharma stocks, exits Biogen; Nifty Pharma tanks 4% in 1 month

    Warren Buffett's Berkshire Hathaway slashed stakes in several pharmaceutical companies such as Abbvie Inc, Bristol-Myers Squibb Co and Merck & Co. in the second quarter of FY21.

  • Cholesterol Lowering Drugs Market Report 2021-2028| Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast
    globenewswire.com

    Cholesterol Lowering Drugs Market Report 2021-2028| Size, Share, Growth, Trends, Revenue, Competitive Analysis, Forecast

    Top Players Covered in the Cholesterol Lowering Drugs Market Research Report Are AstraZeneca, Pfizer Inc., Novartis AG, AbbVie Inc., Sun Pharmaceuticals…

  • Buffett’s firm ups Kroger stake, trims drug holdings
    jamaica-gleaner.com

    Buffett’s firm ups Kroger stake, trims drug holdings

    Billionaire Warren Buffett’s company has again increased the size of its bet on grocery giant Kroger, while scaling back several of its healthcare industry investments. Berkshire Hathaway Inc said in a quarterly update with regulators on Monday…

  • Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios
    markets.businessinsider.com

    Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios

    The latest round of 13F filings from institutional investors is out, revealing to the world the stocks that some of the richest and most successfu…

  • Warren Buffett's Berkshire Hathaway trims US$3.55 billion investment in General Motors
    financialpost.com

    Warren Buffett's Berkshire Hathaway trims US$3.55 billion investment in General Motors

    Berkshire has held General Motors shares for more than nine years, then pulled back on the investment in recent quarters

  • Global Active Pharmaceutical Ingredients/API Market To Reach $274.8 Billion By 2026
    thestreet.com

    Global Active Pharmaceutical Ingredients/API Market To Reach $274.8 Billion By 2026

    SAN FRANCISCO, Aug. 17, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026
    prnewswire.com

    Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • New Software Functionality from Unisys Enables Airlines to Track Status and Location of Individual Cargo Pieces for the First Time
    markets.businessinsider.com

    New Software Functionality from Unisys Enables Airlines to Track Status and Location of Individual Cargo Pieces for the First Time

    BLUE BELL, Pa., Aug. 17, 2021 /PRNewswire/ — Unisys Corporation (NYSE: UIS) today announced the availability of software functionality that for t…

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Iat Reinsurance Co Ltd. Buys CoBank ACB, AgriBank FCB, CoBank ACB, Sells General Electric Co, AbbVie Inc, DCP Midstream LP
    gurufocus.com

    Iat Reinsurance Co Ltd. Buys CoBank ACB, AgriBank FCB, CoBank ACB, Sells General Electric Co, AbbVie Inc, DCP Midstream LP

    GuruFocus Article or News written by insider and the topic is about:

  • Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen
    theedgemarkets.com

    Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

    Warren Buffett's Berkshire Hathaway Inc said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a small new stake in a Merck & Co spinoff, Organon & Co. In the second quarter, Berkshire said it exited a $180 million stake in Biogen Inc and reduced investments in Abbvie Inc, Bristol-Myers Squibb Co and Merck.

  • Warren Buffett's Berkshire Hathaway ups Kroger stake while trimming drug holdings
    foxbusiness.com

    Warren Buffett's Berkshire Hathaway ups Kroger stake while trimming drug holdings

    Berkshire Hathaway Inc. said in a quarterly update with regulators Monday that it picked up nearly 11 million shares of Kroger stock during the second quarter, raising its holdings to 61.8 million shares.

  • Blueshift Asset Management, LLC Buys Apple Inc, Square Inc, Starbucks Corp, Sells SPDR Bloomberg Barclays High Yield Bond ETF, Intel Corp,...
    gurufocus.com

    Blueshift Asset Management, LLC Buys Apple Inc, Square Inc, Starbucks Corp, Sells SPDR Bloomberg Barclays High Yield Bond ETF, Intel Corp, Charter Communications Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen By Reuters
    investing.com

    Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen By Reuters

    Buffett's Berkshire pares drug holdings, sheds Axalta, Biogen

  • swisspartners Advisors Ltd Buys Stellantis NV, D.R. Horton Inc, TotalEnergies SE, Sells Stellantis NV, Consumer Discretionary Select Sector...
    gurufocus.com

    swisspartners Advisors Ltd Buys Stellantis NV, D.R. Horton Inc, TotalEnergies SE, Sells Stellantis NV, Consumer Discretionary Select Sector SPDR, iShares MSCI Japan ETF

    GuruFocus Article or News written by insider and the topic is about:

  • 2 Top Warren Buffett Stocks to Buy Right Now By StockNews
    investing.com

  • Vident Investment Advisory, LLC Buys Luminar Technologies Inc, iRhythm Technologies Inc, Apple Inc, Sells Nuance Communications Inc, NVIDIA...
    gurufocus.com

    Vident Investment Advisory, LLC Buys Luminar Technologies Inc, iRhythm Technologies Inc, Apple Inc, Sells Nuance Communications Inc, NVIDIA Corp, Brooks Automation Inc

    GuruFocus Article or News written by insider and the topic is about:

  • FUKOKU MUTUAL LIFE INSURANCE Co Buys Global X U.S. Preferred ETF, AbbVie Inc, Texas Instruments Inc, Sells General Electric Co,...
    gurufocus.com

    FUKOKU MUTUAL LIFE INSURANCE Co Buys Global X U.S. Preferred ETF, AbbVie Inc, Texas Instruments Inc, Sells General Electric Co, Freeport-McMoRan Inc, Chubb

    GuruFocus Article or News written by insider and the topic is about:

  • Warren Buffett is Buying These 4 Pharmaceutical Stocks, Should You? By StockNews
    investing.com

    Warren Buffett is Buying These 4 Pharmaceutical Stocks, Should You? By StockNews

    Warren Buffett is Buying These 4 Pharmaceutical Stocks, Should You?

  • AMF Pensionsforsakring AB Buys Eli Lilly and Co, Morgan Stanley, Thermo Fisher Scientific Inc, Sells Alibaba Group Holding, AbbVie Inc, The...
    gurufocus.com

    AMF Pensionsforsakring AB Buys Eli Lilly and Co, Morgan Stanley, Thermo Fisher Scientific Inc, Sells Alibaba Group Holding, AbbVie Inc, The Toronto-Dominion Bank

    GuruFocus Article or News written by insider and the topic is about:

  • swisspartners Ltd. Buys Stellantis NV, Deere, The Mosaic Co, Sells Stellantis NV, Zoetis Inc,
    gurufocus.com

    swisspartners Ltd. Buys Stellantis NV, Deere, The Mosaic Co, Sells Stellantis NV, Zoetis Inc,

    GuruFocus Article or News written by insider and the topic is about:

  • Respiratory Syncytial Virus (RSV) Market to Reach $4.2 Billion by 2027: CAGR 14.9%: Astute Analytica
    prnewswire.com

    Respiratory Syncytial Virus (RSV) Market to Reach $4.2 Billion by 2027: CAGR 14.9%: Astute Analytica

    /PRNewswire/ — As per the report “Global Respiratory Syncytial Virus Market – Industry Dynamics, Market Size, and Opportunity Forecast to 2027” published by…

  • Top Analyst Reports for Alibaba, AbbVie & Exxon Mobil
    zacks.com

    Top Analyst Reports for Alibaba, AbbVie & Exxon Mobil

    Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), AbbVie Inc. (ABBV), and Exxon Mobil Corporation (XOM).

  • Genmab Announces Financial Results for the First Half of 2021
    marketscreener.com

    Genmab Announces Financial Results for the First Half of 2021

    –  Operating result 1,500 – 2,400 1,000 – 2,000  Conference Call Genmab will hold a conference call to discuss the results for the first half of 2021 today, Wednesday,… | August 11, 2021

  • 5 Best Blue Chip Dividend Stocks Hedge Funds are Buying
    insidermonkey.com

    5 Best Blue Chip Dividend Stocks Hedge Funds are Buying

    In this article, we will be looking at the 5 best blue chip dividend stocks hedge funds are buying.

  • Dermal Fillers Market Size | Hit USD 6.25 Billion by 2028 and Exhibit 10.8% CAGR
    globenewswire.com

    Dermal Fillers Market Size | Hit USD 6.25 Billion by 2028 and Exhibit 10.8% CAGR

    Top Players Covered in the Dermal Fillers Market Research Report Are Anika Therapeutics Inc. (Massachusetts, U.S.), Suneva Medical (California, U.S.),…

  • 12 Best Blue-Chip Stocks Right Now
    insidermonkey.com

    12 Best Blue-Chip Stocks Right Now

    Blue-chip companies usually have big market caps, strong balance sheets, and solid history. Some examples of the blue-chip stocks are Microsoft Corporation (NASDAQ: MSFT), Apple Inc.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Abbvie Aktie

Das Unternehmen Abbvie aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Biotechnologie, Pharma tätig.

Abbvie ist in mehr als 87 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter First Trust Morningstar Dividend Leaders ETF (CAD-Hedged) gewichtet Abbvie mit 7,03% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Abbvie Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Abbvie am höchsten gewichtet ist Insgesamt in 87 ETFs enthalten

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Abbvie?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero